BioCentury
ARTICLE | Clinical News

Embeda regulatory update

May 2, 2011 7:00 AM UTC

FDA issued a new quarterly report on safety information emerging from its Adverse Events Reporting System (AERS) during 4Q10 in which the agency identified a possible risk of withdrawal symptoms not a...